
Senseonics Holdings SENS
€ 6.21
6.35%
Quartalsbericht 2025-Q3
hinzugefügt 05.11.2025
Senseonics Holdings DSO 2011-2026 | SENS
DSO Jährlich Senseonics Holdings
| 2024 | 2023 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | 10.3 | 220 | 180 | 142 | 194 | 276 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 276 | 10.3 | 170 |
DSO Vierteljährlich Senseonics Holdings
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 69.6 | 66.4 | 78.8 | - | - | - | - | - | - | 12.2 | 6.37 | - | 3.19 | 5.55 | 8.04 | - | 4.28 | 7.5 | 14.4 | 13.3 | 67.2 | 198 | 4.82 K | 33 | 68.4 | 64.2 | 138 | 71.1 | 62.7 | 77.3 | 101 | 106 | 147 | 379 | 300 | 83 | 619 | 1.21 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 4.82 K | 3.19 | 294 |
DSO anderer Aktien in der Diagnostik & Forschung
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Anixa Biosciences
ANIX
|
275 | $ 3.03 | -2.42 % | $ 98.3 K | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 39.07 | -0.24 % | $ 1.09 B | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 33.99 | 1.34 % | $ 366 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Exact Sciences Corporation
EXAS
|
29.9 | $ 102.46 | 0.16 % | $ 19 B | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.07 | -0.65 % | $ 788 M | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.36 | -7.49 % | $ 1.73 M | ||
|
Guardant Health
GH
|
49.2 | $ 112.0 | 1.38 % | $ 13.7 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Co-Diagnostics
CODX
|
101 | - | - | $ 79.8 M | ||
|
Danaher Corporation
DHR
|
57 | $ 218.67 | -0.43 % | $ 160 B | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
Lantheus Holdings
LNTH
|
72 | $ 65.99 | -1.03 % | $ 4.57 B | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
DexCom
DXCM
|
85 | $ 73.0 | -1.35 % | $ 28.2 B | ||
|
NeoGenomics
NEO
|
77.8 | $ 11.92 | -3.87 % | $ 1.51 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 20.34 | -2.21 % | $ 1.09 B | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 10.35 | 0.49 % | $ 294 M | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Personalis
PSNL
|
55.8 | $ 9.39 | -5.82 % | $ 556 M | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
61.3 | $ 144.48 | -3.48 % | $ 23 B | ||
|
QIAGEN N.V.
QGEN
|
30.8 | - | - | $ 10.6 B | ||
|
IQVIA Holdings
IQV
|
78 | $ 228.96 | -2.83 % | $ 41.5 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 209.01 | -1.26 % | $ 10.7 B | ||
|
Thermo Fisher Scientific
TMO
|
69.9 | $ 579.32 | -2.16 % | $ 221 B | ||
|
Trinity Biotech plc
TRIB
|
87.2 | $ 0.82 | -6.65 % | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
44.5 | $ 40.41 | -2.81 % | $ 2.42 B | ||
|
Medpace Holdings
MEDP
|
51.5 | $ 582.85 | -1.72 % | $ 18 B | ||
|
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 185.07 | 1.49 % | $ 20.5 B | ||
|
Biodesix
BDSX
|
41.7 | $ 9.19 | -4.87 % | $ 1.19 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Precipio
PRPO
|
28.1 | $ 24.39 | 0.54 % | $ 31.7 M | ||
|
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 269.44 | -0.14 % | $ 22.6 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 375.8 | -1.22 % | $ 29.2 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 179.1 | -3.66 % | $ 14.8 B | ||
|
IDEXX Laboratories
IDXX
|
43.6 | $ 670.08 | -0.98 % | $ 55.3 B |